Monday, 24 November 2014

Antibacterial Drugs Market Overview 2013 - 2019

This report on antibacterial drugs market studies the current as well as future prospects of the market globally. Antibacterial drugs are agents that are utilized to check the growth of bacterial strains in living organisms, which are responsible for several mild to severe infections. These drugs exhibit bactericidal activity that targets different physiological processes of harmful bacteria, such as, nucleic acid synthesis, cell wall synthesis, protein synthesis, and permeability of cell membrane, thus help treat various infections. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments that are contained in the report. It also provides an overall information and data analysis of the global antibacterial drugs market with respect to market segments based on drug class, and geographic regions.

Browse Global Antibacterial Drugs Market Report with Full TOC at

The market for antibacterial drugs is segmented based on major classes of drugs, namely, aminoglycosides, β-lactams, tetracyclines, sulfonamides, quinolones/fluoroquinolones, macrolides and phenicols. The market for these classes has been extensively analyzed based on the leading drug launch, expiry, efficacy, sales revenue and geographic presence. The market size and forecast in terms of USD million for each of these classes has been provided for the period 2011 to 2019. β-lactams being the largest drug class, has been further classified into three major sub-segments, namely, penicillins, carbapenems, and cephalosporins. Elaborate qualitative information for these subclasses has been provided in separate sub-sections of this report. The report on antibacterial drugs market also provides value percent of compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.

Geographically, the antibacterial drugs market has been categorized into four regions namely, North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market sizes and forecasts for each of these regions have been provided for the period 2011 to 2019 along with CAGR (Value %) for the forecast period 2013 to 2019. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of global antibacterial drugs market and future opportunities has been provided in the market overview section. This section of the report also deals with market attractiveness analysis and Porter’s five forces analysis for the antibacterial drugs market.

The report also includes pipeline analysis for the antibacterial drugs market that comprises sales forecast for various drugs currently under phase III clinical trials and expected to be launched within the forecast period. Some of the major drugs that have been profiled in this section include Tedizolid, Dalbavancin, Oritavancin, Delafloxacin, Ceftolozane/Tazobactam, CAZ-AVI, Surotomycin, Solithromycin, Eravacycline, MK-3415A and Delamanid. The forecast market size in terms of USD million for each of these drugs has been provided for the period 2013 to 2019, considering their launch during the forecast period. This chapter also provides % compounded annual growth rate (CAGR) for each drug for the forecast period 2013 to 2019. This report also includes a chapter on competitive landscape that includes market share analysis of the leading players in the antibacterial drugs market, in terms of their market share (Value %) in the year 2012. A list of recommendations has also been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.

The report also profiles major players of the antibacterial drugs market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi.

The global antibacterial drugs market is segmented as follows:

Antibacterial Drugs Market, by Class

Antibacterial Drugs Market, by Geography
North America
Rest of the World (RoW)

Browse all Pharmaceutical Market Research Reports @

About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

No comments:

Post a Comment